Clinical Trials
4 trialsNCT01375114 2026-05-04
The Effects of Ginseng on Cancer-Related Fatigue
M.D. Anderson Cancer Center
Phase 1/2 Active not recruiting
NCT03375983 2024-02-20
Plasmodium Immunotherapy for Advanced Cancers
CAS Lamvac Biotech Co., Ltd.
Phase 1/2 Recruiting
NCT02561234 2021-11-05
A Multiple Dose, Dose Escalation Trial of AEB1102 in Patients With Advanced Solid Tumors
Aeglea Biotherapeutics
Phase 1/2 Completed
NCT00877773 2016-08-25
Phosphatidylinositol 3 Kinase and Mammalian Target of Rapamycin (PI3K-mTOR) in Advanced Cancer Patients
M.D. Anderson Cancer Center
Phase 1/2 Terminated